Author | Ryan J. Sullivan, MD | OncLive

Author | Ryan J. Sullivan, MD

Articles

Dr. Sullivan Discusses Role of Dabrafenib Plus Trametinib in Melanoma

November 23, 2019

Video

Ryan J. Sullivan, MD, discusses the significance of the BRAF/MEK combination dabrafenib and trametinib, which was the first BRAF/MEK inhibitor regimen to be approved by the FDA for the treatment of patients with BRAF V600E–positive stage III melanoma following complete resection.

Dr. Sullivan on Practice-Changing COMBI-d and COMBI-v Trials

July 05, 2019

Video

Ryan J. Sullivan, MD, discusses the results of the COMBI-d and COMBI-v studies that led to changes in practice for patients with BRAF V600-mutant unresectable or metastatic melanoma.

Dr. Sullivan on Immunotherapy Approaches in Melanoma

April 29, 2019

Video

Ryan J. Sullivan, MD, assistant professor of medicine, Harvard Medical School, assistant professor of hematology/oncology, Massachusetts General Hospital, discusses treatment approaches with immunotherapy for patients with melanoma.

Dr. Sullivan on Findings From the ENCORE 601 Trial in Melanoma

April 10, 2019

Video

Ryan J. Sullivan, MD, instructor of medicine, Harvard Medical School, assistant in medicine, Massachusetts General Hospital (MGH), MGH Cancer Center, discusses findings from the ENCORE 601 trial in melanoma.

x